Clinical trial
Preoperative Combined Radiation and Chemotherapy - Rectal Cancer
NCT00232453 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00232453 |
|---|---|
| Title | Preoperative Combined Radiation and Chemotherapy - Rectal Cancer |
| Official title | A Phase II Protocol of Preoperative Combined Radiation and Chemotherapy for Resectable Primary Rectal Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Neoplasms |
| Intervention type | Procedure |
| Interventions | Combined Radiation and Chemotherapy |
| Enrollment | 34 |
| Start date | Mar 1, 2001 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Oct 4, 2005 |
| Last update posted | Feb 15, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: